UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015945
Receipt number R000018494
Scientific Title Multicenter study for discover of useful biomarkers in differential diagnosis and assessment of disease activity in patients with IgG4-related disease
Date of disclosure of the study information 2014/12/15
Last modified on 2019/12/19 16:10:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter study for discover of useful biomarkers in differential diagnosis and assessment of disease activity in patients with IgG4-related disease

Acronym

Study of biomarkers in IgG4-related disease

Scientific Title

Multicenter study for discover of useful biomarkers in differential diagnosis and assessment of disease activity in patients with IgG4-related disease

Scientific Title:Acronym

Study of biomarkers in IgG4-related disease

Region

Japan


Condition

Condition

IgG4-related disease

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the association between diagnosis or disease activity (severity and organ disorder) and biomarkers detected by ELISA methods before and after treatment in patients with IgG4-related disease

Basic objectives2

Others

Basic objectives -Others

Verify the association of diagnosis and disease (severity and organ failure) and biomarkers of IgG4-related disease

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

IgG4 diagnosis of related diseases and disease

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-IgG4-related disease patients(30cases)
-Discrimination is required disease (Castlemans disease,malignant lymphoma,etc.) patients (10 cases)
-Healthy volunteers consent was obtained in our hospital staff (20 cases)

Key exclusion criteria

none

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinya Kawashiri

Organization

Nagasaki University Graduate School of Biomedical Sciences All Rights Reserved

Division name

Department of Public Health

Zip code


Address

1-7-1 Sakamoto,Nagasaki

TEL

095-819-7067

Email

shin-ya@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinya Kawashiri

Organization

Nagasaki University Graduate School of Biomedical Sciences All Rights Reserved

Division name

Department of Public Health

Zip code


Address

1-7-1 Sakamoto,Nagasaki

TEL

095-819-7067

Homepage URL


Email

shin-ya@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 15 Day


Related information

URL releasing protocol

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Publication of results

Unpublished


Result

URL related to results and publications

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Number of participants that the trial has enrolled

72

Results

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Results date posted

2019 Year 12 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Participant flow

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Adverse events

-

Outcome measures

https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1777-7

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 11 Month 06 Day

Date of IRB

2014 Year 10 Month 28 Day

Anticipated trial start date

2014 Year 11 Month 06 Day

Last follow-up date

2016 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2016 Year 10 Month 31 Day


Other

Other related information

Discovery research


Management information

Registered date

2014 Year 12 Month 15 Day

Last modified on

2019 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018494


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name